  See all
 |
Articles: Neuro/Psych Pharmacol |
Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy
American Journal of Psychiatry, 11/06/09
A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies
Archives of General Psychiatry, 11/06/09 Study on the efficacy and tolerability of amisulpride in medical/surgical inpatients with delirium admitted to a general hospital
European Psychiatry, 11/06/09
Prior Articles
Effectiveness of community treatment orders for treatment of schizophrenia with oral or depot antipsychotic medication: changes in problem behaviours and social functioning
Australian and New Zealand Journal of Psychiatry, 11/05/09 Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study
Nicotine & Tobacco Research, 11/05/09 Glycine Receptors in the Nucleus Accumbens Involved in the Ethanol Intake-Reducing Effect of Acamprosate
Alcoholism, 10/29/09 Experience with Intravenous Levetiracetam in Status Epilepticus: A Retrospective Case Series
CNS Drugs, 10/29/09 Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09 Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study
CNS Drugs, 10/28/09 Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment
Drug and Alcohol Dependence, 10/27/09 The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone
Schizophrenia Research, 10/26/09 Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study
Drug and Alcohol Dependence, 10/26/09 Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Evidence Based Medicine
Revew Article
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09 Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Drug and Alcohol Dependence, 10/23/09 A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Biological Psychiatry, 10/23/09 Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09 Risperidone dose for schizophrenia
Cochrane Reviews, 10/22/09
Revew Article
Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial
JAMA, 10/22/09 Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway
Psychoneuroendocrinology, 10/22/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction
more...
|
250 Available Pages
|
|
